MH

Michael R. Hanley

AP Amylin Pharmaceuticals: 12 patents #13 of 151Top 9%
AL Astrazeneca Pharmaceuticals Lp: 6 patents #9 of 76Top 15%
CH Chemocentryx: 4 patents #62 of 107Top 60%
RP Resolvex Pharmaceuticals: 2 patents #3 of 9Top 35%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
TL Takeda Pharmaceutical Company Limited: 1 patents #859 of 1,531Top 60%
📍 Corte Madera, CA: #7 of 143 inventorsTop 5%
🗺 California: #28,827 of 386,348 inventorsTop 8%
Overall (All Time): #220,888 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDate
11529363 Methods of treating cancer in pediatric patients Sharon Bowen, David Kerstein, Karthik Venkatakrishnan 2022-12-20
9453063 Hybrid polypeptides with selectable properties Odile Esther Levy, Carolyn M. Jodka, Diana Y. Lewis, Christopher J. Soares, Soumitra S. Ghosh +3 more 2016-09-27
9133260 GIP analog and hybrid polypeptides with selectable properties Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +9 more 2015-09-15
8895498 GIP and exendin hybrid polypeptides Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra G. Ghosh +10 more 2014-11-25
8697647 Hybrid polypeptides with selectable properties Odile Esther Levy, Carolyn M. Jodka, Diana Y. Lewis, Christopher J. Soares, Soumitra S. Ghosh +3 more 2014-04-15
8598120 Methods for treatment using amylin family peptides Christopher J. Soares, Diana Y. Lewis, David G. Parkes, Carolyn M. Jodka, Kathryn S. Prickett +3 more 2013-12-03
8497240 DPP-IV resistant GIP hybrid polypeptides with selectable properties Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +10 more 2013-07-30
8404637 GIP analog and hybrid polypeptides with selectable properties Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +9 more 2013-03-26
8389477 Amylin and amylin agonists for treating psychiatric diseases and disorders Kevin D. Laugero, Christine M. Mack, David G. Parkes, Andrew A. Young 2013-03-05
8309522 Neuromedin and FN-38 peptides for treating psychiatric diseases Kevin D. Laugero, Christine M. Mack, David G. Parkes, Paul McGonigle 2012-11-13
8263545 GIP analog and hybrid polypeptides with selectable properties Odile Esther Levy, Alain D. Baron, Lawrence J. D'Souza, Mary Erickson, Soumitra S. Ghosh +10 more 2012-09-11
8114958 Amylin family peptides Christopher J. Soares, Diana Y. Lewis, David G. Parkes, Carolyn M. Jodka, Kathryn S. Prickett +3 more 2012-02-14
8076288 Hybrid polypeptides having glucose lowering activity Odile Esther Levy, Carolyn M. Jodka, Diana Y. Lewis, Christopher J. Soares, Soumitra S. Ghosh +3 more 2011-12-13
7671023 Amylin agonist for treating depression, anxiety disorder and schizophrenia Kevin D. Laugero, Christine M. Mack, David G. Parkes, Andrew A. Young 2010-03-02
7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use Daniel W. Goodman, Stuart L. Bursten, Charles N. Serhan 2009-09-29
7378444 Analogues of lipid mediators derived from omega-3 PUFAs and methods of use Daniel W. Goodman, Stuart L. Bursten, Charles N. Serhan 2008-05-27
RE39849 Methods for identifying modulators of CCX CKR activity Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Thomas Schall 2007-09-18
7108990 Chemokine receptor Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Thomas Schall 2006-09-19
6998239 Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Dale Talbot, Thomas Schall 2006-02-14
6835547 Methods for identifying modulators of CCX CKR activity Jennifa Gosling, Daniel Dairaghi, Zhenhua Miao, Dale Talbot, Thomas Schall 2004-12-28